Diagnostic challenges of benign/incidental lesions at Liver MRI and CEUS It will address the topic of MR imaging of benign lesions.

Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Bracco Imaging has won the Gold Medal from EcoVadis The company is now proudly sporting the EcoVadis gold medal for what it has managed to achieve in four key areas: environment, ethics, labour and human rights, sustainable procurement.

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

EuSoMII/Bracco AI Contest Pisa, Italy, on the 13th and 14th of October 2023, the European Society of Medical Imaging Informatics hosted its annual gathering. Aptly titled "AI: Connecting the dots," this event brought together minds from different corners of the medical and radiology world to explore the boundless possibilities of Artificial Intelligence.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.